Cryopreservation of Dendritic Cells for Cancer Therapy

Research output: Contribution to journalArticleResearch

Authors

  • Tarek Deeb
  • Lena Zeh
  • Tim Sören Frederik Rittinghaus
  • Claudia Dettmar-Richardt
  • Simon Grammel
  • Birgit Glasmacher

Research Organisations

External Research Organisations

  • PetBioCell GmbH
View graph of relations

Details

Translated title of the contributionKryokonservierung von dendritischen Zellen für die Krebstherapie
Original languageEnglish
Article number300
JournalProblems of cryobiology :scientific and theoretical journal
Volume32
Issue number4
Publication statusPublished - 30 Dec 2022

Abstract

In recent decades, cell therapy has become increasingly important as a complementary approach to cancer treat-ment. Dendritic cell therapy shows great potential for the treatment of cancer. Better availability of this cell therapy should be ensured by cryopreservation. The project is dedicated to the investigation of a supply chain model in which equine dendritic cells derived from monocytes are first cultured, shipped and cryopreserved. Then, the samples are thawed and shipped back after three specifi c time periods corresponding to the real therapeutic process. In total, the quality, as well as the quantity (automatic cell counting as well as vitality determination) of ൱൰ samples from four diff erent animals, is evaluated before and after the cryopreservation process in terms of storage time, con-centration, and total volume. Here, a composition of ൯ mil-lion cells in ൫ ml seems to be the most suitable for the pro-cedure and provided better results (overall vitality ≥൱൲%). In addition, isotonic saline was found to have the potential to replace autologous plasma in cryoprotectants.

Sustainable Development Goals

Cite this

Cryopreservation of Dendritic Cells for Cancer Therapy. / Deeb, Tarek; Zeh, Lena; Rittinghaus, Tim Sören Frederik et al.
In: Problems of cryobiology :scientific and theoretical journal, Vol. 32, No. 4, 300, 30.12.2022.

Research output: Contribution to journalArticleResearch

Deeb, T, Zeh, L, Rittinghaus, TSF, Dettmar-Richardt, C, Grammel, S & Glasmacher, B 2022, 'Cryopreservation of Dendritic Cells for Cancer Therapy', Problems of cryobiology :scientific and theoretical journal, vol. 32, no. 4, 300. https://doi.org/10.15407/cryo32.04.300a
Deeb, T., Zeh, L., Rittinghaus, T. S. F., Dettmar-Richardt, C., Grammel, S., & Glasmacher, B. (2022). Cryopreservation of Dendritic Cells for Cancer Therapy. Problems of cryobiology :scientific and theoretical journal, 32(4), Article 300. https://doi.org/10.15407/cryo32.04.300a
Deeb T, Zeh L, Rittinghaus TSF, Dettmar-Richardt C, Grammel S, Glasmacher B. Cryopreservation of Dendritic Cells for Cancer Therapy. Problems of cryobiology :scientific and theoretical journal. 2022 Dec 30;32(4):300. doi: 10.15407/cryo32.04.300a
Deeb, Tarek ; Zeh, Lena ; Rittinghaus, Tim Sören Frederik et al. / Cryopreservation of Dendritic Cells for Cancer Therapy. In: Problems of cryobiology :scientific and theoretical journal. 2022 ; Vol. 32, No. 4.
Download
@article{2c246af3dfce48e29ce6a8aa08a8aaf3,
title = "Cryopreservation of Dendritic Cells for Cancer Therapy",
abstract = "In recent decades, cell therapy has become increasingly important as a complementary approach to cancer treat-ment. Dendritic cell therapy shows great potential for the treatment of cancer. Better availability of this cell therapy should be ensured by cryopreservation. The project is dedicated to the investigation of a supply chain model in which equine dendritic cells derived from monocytes are first cultured, shipped and cryopreserved. Then, the samples are thawed and shipped back after three specifi c time periods corresponding to the real therapeutic process. In total, the quality, as well as the quantity (automatic cell counting as well as vitality determination) of ൱൰ samples from four diff erent animals, is evaluated before and after the cryopreservation process in terms of storage time, con-centration, and total volume. Here, a composition of ൯ mil-lion cells in ൫ ml seems to be the most suitable for the pro-cedure and provided better results (overall vitality ≥൱൲%). In addition, isotonic saline was found to have the potential to replace autologous plasma in cryoprotectants.",
author = "Tarek Deeb and Lena Zeh and Rittinghaus, {Tim S{\"o}ren Frederik} and Claudia Dettmar-Richardt and Simon Grammel and Birgit Glasmacher",
year = "2022",
month = dec,
day = "30",
doi = "10.15407/cryo32.04.300a",
language = "English",
volume = "32",
number = "4",

}

Download

TY - JOUR

T1 - Cryopreservation of Dendritic Cells for Cancer Therapy

AU - Deeb, Tarek

AU - Zeh, Lena

AU - Rittinghaus, Tim Sören Frederik

AU - Dettmar-Richardt, Claudia

AU - Grammel, Simon

AU - Glasmacher, Birgit

PY - 2022/12/30

Y1 - 2022/12/30

N2 - In recent decades, cell therapy has become increasingly important as a complementary approach to cancer treat-ment. Dendritic cell therapy shows great potential for the treatment of cancer. Better availability of this cell therapy should be ensured by cryopreservation. The project is dedicated to the investigation of a supply chain model in which equine dendritic cells derived from monocytes are first cultured, shipped and cryopreserved. Then, the samples are thawed and shipped back after three specifi c time periods corresponding to the real therapeutic process. In total, the quality, as well as the quantity (automatic cell counting as well as vitality determination) of ൱൰ samples from four diff erent animals, is evaluated before and after the cryopreservation process in terms of storage time, con-centration, and total volume. Here, a composition of ൯ mil-lion cells in ൫ ml seems to be the most suitable for the pro-cedure and provided better results (overall vitality ≥൱൲%). In addition, isotonic saline was found to have the potential to replace autologous plasma in cryoprotectants.

AB - In recent decades, cell therapy has become increasingly important as a complementary approach to cancer treat-ment. Dendritic cell therapy shows great potential for the treatment of cancer. Better availability of this cell therapy should be ensured by cryopreservation. The project is dedicated to the investigation of a supply chain model in which equine dendritic cells derived from monocytes are first cultured, shipped and cryopreserved. Then, the samples are thawed and shipped back after three specifi c time periods corresponding to the real therapeutic process. In total, the quality, as well as the quantity (automatic cell counting as well as vitality determination) of ൱൰ samples from four diff erent animals, is evaluated before and after the cryopreservation process in terms of storage time, con-centration, and total volume. Here, a composition of ൯ mil-lion cells in ൫ ml seems to be the most suitable for the pro-cedure and provided better results (overall vitality ≥൱൲%). In addition, isotonic saline was found to have the potential to replace autologous plasma in cryoprotectants.

U2 - 10.15407/cryo32.04.300a

DO - 10.15407/cryo32.04.300a

M3 - Article

VL - 32

JO - Problems of cryobiology :scientific and theoretical journal

JF - Problems of cryobiology :scientific and theoretical journal

SN - 0233-7673

IS - 4

M1 - 300

ER -

By the same author(s)